Perceptive Advisors LLC Rhythm Pharmaceuticals, Inc. Transaction History
Perceptive Advisors LLC
- $3 Billion
- Q4 2024
A detailed history of Perceptive Advisors LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 3,680,473 shares of RYTM stock, worth $209 Million. This represents 6.86% of its overall portfolio holdings.
Number of Shares
3,680,473
Previous 3,560,214
3.38%
Holding current value
$209 Million
Previous $187 Million
10.3%
% of portfolio
6.86%
Previous 4.87%
Shares
16 transactions
Others Institutions Holding RYTM
# of Institutions
214Shares Held
66.7MCall Options Held
454KPut Options Held
57K-
Black Rock Inc. New York, NY6.74MShares$382 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$373 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$345 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$345 Million3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$195 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.16B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...